Optimi Health’s first UK psilocybin export signals bigger test for GMP psychedelic manufacturing
Find out how Optimi Health’s UK psilocybin export could reshape psychedelic trial supply and what risks remain for Phase 2 research.
Pharma & Biotech
Pharma & Biotech
Why Cartesian Therapeutics’ WestGene pact could intensify the race for autoimmune cell therapy
Find out how Cartesian Therapeutics’ WestGene deal could reshape in vivo CAR-T strategy in autoimmune disease and what risks remain.
Pharma & Biotech
Why FDA alignment could move Alterity’s ATH434 closer to a pivotal MSA test
Find out how FDA alignment on ATH434 could shape Alterity Therapeutics’ pivotal Phase 3 path in multiple system atrophy.
Pharma & Biotech
Why TG Therapeutics’ BRIUMVI data could open a new treatment path in myasthenia gravis
Find out how TG Therapeutics’ BRIUMVI data could shape a new maintenance strategy in myasthenia gravis treatment.
Pharma & Biotech
Harbour BioMed’s HBM7004 China IND acceptance sharpens the race for B7-H4 cancer targets
Find out how Harbour BioMed’s HBM7004 China IND acceptance could reshape B7-H4 solid tumor immunotherapy development.
Pharma & Biotech
Sensorion’s SENS-601 strategy signals a sharper bet on larger genetic hearing loss markets
Find out how Sensorion’s SENS-601 regulatory push could reshape GJB2 hearing loss gene therapy and clinical strategy.
Pharma & Biotech
Can Zetagen’s ZetaMet Phase 2a data change how metastatic breast cancer bone lesions are treated?
Find out how Zetagen’s ZetaMet Phase 2a data may reshape treatment of metastatic breast cancer bone lesions.
Pharma & Biotech
Why Lilly’s expanded Ebglyss label could reset dosing expectations in atopic dermatitis biologics
Ebglyss gains an every-eight-week FDA maintenance option, raising new questions for atopic dermatitis biologic competition.
Pharma & Biotech
Enveric Biosciences’ EB-003 push highlights the next battle in neuroplastogen drug development
Read how Enveric Biosciences’ EB-003 investor push reshapes CNS biotech risk, regulation and clinical strategy.
Medical Devices & Diagnostics
Why Multi Radiance Medical’s MR5 ACTIV PRO clearance matters for tendon pain treatment
Read how Multi Radiance Medical’s MR5 ACTIV PRO clearance could reshape non-invasive tennis elbow pain treatment and what risks remain.